Skip to Content

Archives: Actions

MM is neutral at best toward ALD

by Matthew Snodgrass

  • Posted in
  • Comments Off on MM is neutral at best toward ALD

MM is neutral toward RHC

by Matthew Snodgrass

  • Posted in
  • Comments Off on MM is neutral toward RHC

MM is neutral towards the ASX200

by Matthew Snodgrass

  • Posted in
  • Comments Off on MM is neutral towards the ASX200

MM are trimming CBA in the Active Income Portfolio, taking part profit around $161.00

by James Gerrish

  • Posted in
  • Comments Off on MM are trimming CBA in the Active Income Portfolio, taking part profit around $161.00

MM are buying ANZ in the Active Income Portfolio, allocating 5% around $29.42

by James Gerrish

  • Posted in
  • Comments Off on MM are buying ANZ in the Active Income Portfolio, allocating 5% around $29.42

MSFT remains a core holding in the International Equities Portfolio

by Matthew Snodgrass

  • Posted in
  • Comments Off on MSFT remains a core holding in the International Equities Portfolio

MM is bullish and long PXA in the Emerging Companies Portfolio

by Matthew Snodgrass

  • Posted in
  • Comments Off on MM is bullish and long PXA in the Emerging Companies Portfolio

MM believes the risk/reward in ANZ is appealing ~$29.50 relative to CBA at $161

by Matthew Snodgrass

  • Posted in
  • Comments Off on MM believes the risk/reward in ANZ is appealing ~$29.50 relative to CBA at $161

MM likes MGR below $2

by Matthew Snodgrass

  • Posted in
  • Comments Off on MM likes MGR below $2

MM is cautiously bullish toward Pfizer

by Matthew Snodgrass

  • Posted in
  • Comments Off on MM is cautiously bullish toward Pfizer
Back to top